Glonghui, April 11 | Colon Pharmaceutical (002422.SZ) rose more than 5%, and its stock price returned above 30 yuan, with a market value of nearly 50 billion yuan. According to the news, the company's net profit for the first quarter was 950 million yuan to 110 billion yuan, an increase of 16.64%-35.06% over the previous year. During the reporting period, the company increased market development and continued to optimize the product structure. Sales of infusion and non-infusion preparations increased, and profits increased year-on-year.